2026 Medicare Costs Are Rising — But New Drug-Price Negotiations Promise Major Relief in the Years Ahead

2026 Medicare Costs: What's Actually Increasing?

Part B Premiums and Deductibles Are Up Again

CMS confirmed that Medicare Part B premiums will increase by roughly 10% in 2026, reversing last year's slight dip and creating one of the largest single-year jumps in recent memory. The higher premium will consume a noticeable share of the 2026 Social Security COLA, leaving many beneficiaries with lower real take-home income.

The Part B annual deductible is also climbing — a trend that has continued almost every year for the past decade. These changes affect nearly all beneficiaries enrolled in Original Medicare and those in Medicare Advantage plans that pass through Part B cost-sharing.

Part D Out-of-Pocket Costs Are Rising in 2026

Part D deductibles and cost-sharing will increase once again in 2026, particularly affecting beneficiaries who take multiple brand-name medications. Many Part D enrollees will also face higher coinsurance payments during the initial coverage stage as plan sponsors respond to shifting drug-pricing rules going into effect next year.

Medicare Advantage Remains Mostly Stable for 2026

Premiums Expected to Decline Slightly

CMS projects that Medicare Advantage premiums will decline modestly for 2026, despite broader healthcare inflation. Plan availability, quality ratings, and supplemental benefits remain stable nationwide.

Supplemental Benefits Holding Steady

Most Medicare Advantage plans will continue offering extra benefits such as:

• Vision exams and glasses
• Hearing exams and hearing aid discounts
• Dental cleanings and X-rays
• OTC allowance cards
• Limited transportation benefits

While the overall benefit structure is not changing dramatically, beneficiaries should review limits carefully, as some insurers are tightening coverage caps due to rising healthcare costs.

CMS Announces New Drug-Price Negotiation Savings

15 High-Cost Drugs Will See 44% Average Price Reductions

CMS revealed this week that it successfully negotiated lower prices for 15 major drugs, resulting in approximately $12 billion in savings compared to previous pricing. These medications include common treatments for:

• Cancer
• Cardiovascular disease
• Chronic inflammatory disorders
• Autoimmune diseases
• Respiratory conditions

These negotiated "Maximum Fair Prices" (MFPs) will take effect on January 1, 2027 — not 2026 — but CMS emphasized that this is "the most significant expansion of Medicare negotiating power to date."

How This Will Help Beneficiaries

While these savings do not affect 2026 pricing, they will likely reduce out-of-pocket costs significantly in 2027 and beyond, especially for beneficiaries relying on specialty medications that currently cost thousands per month.

Big Policy Shift: Site-Neutral Payment Reform

Hospitals to Receive Reduced Reimbursements for Certain Services

Beginning in 2026, Medicare will implement site-neutral payments for many outpatient drug-administration services delivered in hospital outpatient departments. In practical terms, this means services like chemotherapy infusions performed at off-campus facilities will be reimbursed at physician-office rates, which are substantially lower.

Possible Downsides: Rural Access Risks

Rural hospitals have warned that reduced reimbursement could threaten access to infusion centers and cancer treatment hubs, particularly in underserved regions. CMS acknowledged this but maintains that long-term savings will outweigh risks.

Open Enrollment: What Beneficiaries Should Do Now

Open Enrollment runs October 15 – December 7, giving beneficiaries limited time to switch plans or reassess their health and drug coverage for 2026. Medicare Rights Center emphasizes reviewing:

• Prescription drug needs
• Preferred pharmacies
• Specialist networks
• Supplemental benefits
• Total out-of-pocket exposure

Why This Year Matters More Than Usual

Because 2026 includes rising deductibles, higher Part B premiums, shifting Part D benefit structures, new site-neutral payment reforms, and early signs of formulary tightening — it is especially important for beneficiaries to compare plans carefully.

What This All Means for 2026 and 2027

2026 is shaping up to be a year of higher Medicare costs, but the outlook improves sharply beginning in 2027, when the biggest wave of prescription drug savings in Medicare history begins. Beneficiaries should prepare now — by reviewing their plan options, checking prescription coverage, and understanding how new billing reforms may affect their care.